UgenTec
Start with FastFinder

Announcing SENTiNAT®200, a brand new sample-to-result platform-8

Sentinel Diagnostics today announced its new end-to-end platform for molecular diagnostics, dubbed SENTiNAT®200. The platform will support the full ra...

Announcing SENTiNAT®200, a brand new sample-to-result platform

Sentinel Diagnostics today announced its new end-to-end platform for molecular diagnostics, dubbed SENTiNAT®200. The platform will support the full ra...

Announcing SENTiNAT®200, a brand new sample-to-result platform-5

Sentinel Diagnostics today announced its new end-to-end platform for molecular diagnostics, dubbed SENTiNAT®200. The platform will support the full ra...

Announcing SENTiNAT®200, a brand new sample-to-result platform

Sentinel Diagnostics today announced its new end-to-end platform for molecular diagnostics, dubbed SENTiNAT®200. The platform will support the full ra...

Announcing SENTiNAT®200, a brand new sample-to-result platform

Sentinel Diagnostics today announced its new end-to-end platform for molecular diagnostics, dubbed SENTiNAT®200. The platform will support the full ra...

Announcing SENTiNAT®200, a brand new sample-to-result platform

Sentinel Diagnostics today announced its new end-to-end platform for molecular diagnostics, dubbed SENTiNAT®200. The platform will support the full ra...

Load more
Start with FastFinder
For the latest version of the instructions for use, click this link. IFU in paper format can be requested at support@ugentec.com.
Copyright 2025
  • Kempische Steenweg 303/105, 3500 Hasselt Belgium (map)
  • 1 Mifflin Place, Suite 400 Cambridge, MA 02138, USA (map)
Contact: info@ugentec.com | +32 78 48 44 79 | VAT number: BE05 5197 6421